Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)
Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)
复制标题
DOI：
10.1007/s00428-011-1177-8
复制
发表时间：
2012-01-01
期刊：
影响因子：
3.5
通讯作者：
Kuipers, E. J.
中科院分区：
文献类型：
--
作者：
Dinis-Ribeiro, M.;Areia, M.;Kuipers, E. J.
萎缩性胃炎、肠化生和胃上皮异型增生很常见，与患胃癌的风险增加有关。在缺乏指南的情况下，对这些癌前疾病患者的管理存在着巨大的差异。因此，欧洲胃肠内窥镜学会、欧洲幽门螺杆菌研究小组、欧洲病理学会和葡萄牙消化内窥镜学会共同努力，制定了关于癌症前疾病和胃部病变患者管理的循证指南。由来自24个国家的63名专家组成的多学科小组通过重复在线投票和2011年6月在葡萄牙波尔图举行的一次会议提出了这些建议。这些建议强调了胃萎缩和化生患者癌症风险的增加，以及对高度不典型增生患者进行适当分期的必要性，并侧重于治疗和监测的适应症和方法。
Atrophic gastritis, intestinal metaplasia, and epithelial dysplasia of the stomach are common and are associated with an increased risk for gastric cancer. In the absence of guidelines, there is wide disparity in the management of patients with these premalignant conditions. The European Society of Gastrointestinal Endoscopy, the European Helicobacter Study Group, the European Society of Pathology, and the Sociedade Portuguesa de Endoscopia Digestiva have therefore combined efforts to develop evidence-based guidelines on the management of patients with precancerous conditions and lesions of the stomach. A multidisciplinary group of 63 experts from 24 countries developed these recommendations by means of repeat online voting and a meeting in June 2011 in Porto, Portugal. The recommendations emphasize the increased cancer risk in patients with gastric atrophy and metaplasia and the need for adequate staging in the case of high-grade dysplasia, and they focus on treatment and surveillance indications and methods.